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T helper cell differentiation is controlled by a network of transcription factors. In this issue of Immunity, Yagi
et al. (2010) describe the opposing effects of transcription factors Runx3 and GATA3 in the network
promoting T helper 1 cell development.In a reductionist view of T helper (Th) cell
differentiation, cartoons often portray a
single ‘‘master regulator’’ transcription
factor associated with the development
of each subset. In reality, the coordinated
activity of multiple transcription factors is
required to promote a T helper cell pheno-
type and to induce the expression of indi-
vidual genes.
During Th1 cell development, the induc-
tion of T-bet, a T-box transcription factor
that promotes the expression of many
Th1 cell genes, is initially through an inter-
feron-g-signal transducer and activator of
transcription 1 (IFNg-STAT1)-dependent
phase and then through an interleukin-12
(IL-12)-STAT4-dependent phase (Ligh-
vani et al., 2001; Schulz et al., 2009).
However, this is not a simple linear
pathway. STAT4 and T-bet cooperate
in the activation of many Th1 genes,
although each can activate a subset of
genes expressed in Th1 cells in the
absence of the other factor (Thieu et al.,
2008). The transcription factor Runx3 is
also part of this network, being induced
by STAT4 and T-bet and cooperating
with T-bet in the induction of Ifng and the
repression of Il4 (Djuretic et al., 2007;
Naoe et al., 2007; Thieu et al., 2008).
Yagi et al. (2010) provide data from
a series of elegant experiments designed
to further understand how Runx3 contrib-
utes to Ifng regulation. Their interest was
initially piqued when studying the function
of GATA3, the critical transcription factor
for Th2 development, using mice with
a conditionally deleted Gata3 allele. They
noticed that although GATA3-deficient
T cells cultured under Th2 cell-polarizing
conditions had decreased Th2 cell cyto-
kine production, they had increased IFN-g
secretion that was not accompanied
either by STAT4 activation or induction
of T-bet expression. These results sug-500 Immunity 32, April 23, 2010 ª2010 Elsevgested that additional transcription factors
were involved in the induction of Ifng
independent of T-bet and STAT4. They
demonstrated that Runx3 expression
was modestly increased and that expres-
sion of Eomesodermin (Eomes), another
T-box transcription factor that is associ-
ated with Ifng regulation in CD8+ T cells,
was more dramatically increased in
GATA3-deficient Th2 cell cultures. They
further showed that Runx3- or Eomes-
expressing retroviruses transduced into
Th2 cultures were able to promote IFN-g
production. The induction of IFN-g was
not entirely dependent on T-bet because
Eomes and Runx3 promoted IFN-g
production in Tbx21/ cells, and Runx3
was able to induce IFN-g production in
the presence of a dominant-negative
T-bet that also blocks Eomes activity.
However, it is not clear whether this repre-
sents a separate pathway and, whether in
GATA3-sufficient cells, there are signals
that might induce Runx3 expression inde-
pendently of T-bet and STAT4.
Yagi et al. (2010) show that retroviral
expression of Runx3 induced Eomes
mRNA, suggesting that a T-bet-Runx3-
Eomes pathway is operating in promoting
Ifng expression, where each factor could
have direct effects on the Ifng gene
(Figure 1). Eomes is detected at high
amounts in Gata3/ Th2 cell cultures,
but it is still unknown what would induce
it in wild-type cells because Eomes was
undetectable by intracellular staining in
wild-type Th2 cells or in Th1 cells. Another
report, using quantitative PCR, observed
increased expression of Eomes in CD4+
T cells that lack expression of STAT6,
a GATA3-inducing factor (Yang et al.,
2008), further supporting potent role for
a STAT6-GATA3 pathway in inhibiting
Eomes expression. Importantly, Yagi et al.
(2010) demonstrated the important roleier Inc.of Runx3 in Eomes activity by showing
that Th2 cultures of cells that are triply defi-
cient in GATA3, T-bet, and Runx3 had
diminished IFN-g production compared
to cells deficient only in GATA3 and T-bet
(approximately half of the Eomes-positive
cells in double-deficient cells were IFN-g
positive versus only 17% in triple-deficient
cultures). These results suggest that
whereas Eomes can induce IFN-gproduc-
tion, activity is not optimal in the absence
of other factors and Runx3 is required
for the STAT4-T-bet-independent regula-
tion of IFN-g. Answering the question of
whether limited expression of Eomes,
that is undetectable by intracellular stain-
ing, is important for IFN-g production
awaits the generation of Eomes condi-
tional mutant mice.
The authors go on to further charac-
terize the ability of Runx3 to contribute
to Ifng expression. They demonstrated
that a dominant-negative Runx3 reduced
IFN-g production from WT Th1 cells and
that CBF-b, the binding partner of multiple
Runx family members, bound to the Ifng
gene in a pattern that largely overlaps
with the binding pattern of T-bet. This is
consistent with the previous report sug-
gesting the cooperative binding of Runx3
and T-bet to the Ifng promoter (Djuretic
et al., 2007). It will be very important
to see further analysis of the T-bet and
Runx3 ChIP-seq data sets produced by
Yagi et al. (2010) to develop a more
complete understanding of how these
factors interact in programming Th1 cell
gene expression.
As suggested by the initial observa-
tions, the ability of Runx3 to activate the
Ifng gene is dependent on the amount of
GATA3 expression. Using retroviral trans-
duction and analysis of cells across a
range of expression of both Runx3
and GATA3, they demonstrated that the
Figure 1. Transcriptional Network in Th1 Cells
Cytokine signaling pathways activate transcription factors that have direct effects on the Ifng gene. STAT1
and STAT4 initiate a cascade of transcription factor induction through regulation of T-bet and other down-
stream factors, each of which can also bind to, and activate, the Ifng gene. Targets of GATA3-mediated
repression are indicated by red flat arrows. Yagi et al. (2010) have added to this network by demonstrating
that Runx3 is a target of GATA3 and that in the absence of GATA3, Runx3 and Eomes mediate Ifng induc-
tion in the absence of the upstream factors STAT4 and T-bet.
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independent of GATA3. In contrast, the
ability of Runx3 to stimulate IFN-g pro-
duction was severely limited by GATA3,
and in cells expressing high amounts of
GATA3, even high expression of Runx3
was unable to increase IFN-g production.
The basis for this is a physical interaction
between Runx3 and portions of GATA3
that include the N-terminal region and
the zinc finger. These observations are
confirmed by another report that demon-
strates the ability of Runx3 to induce
IFN-g production and interact with GATA3
(Kohu et al., 2009).
An additional insight into the negative-
regulationof Il4 is provided by experiments
that compare Runx3-mediated repression
of Il4 in wild-type and Tbx21/ Th2 cells.
A previous report suggested that T-bet
and Runx3 cooperate in the repression of
Il4 by binding to the Il4 HSIV element,
and demonstrated that T-bet-mediated
repression of Il4 required Runx3 (Djuretic
et al., 2007). Yagi et al. (2010) demon-
strated that Runx3 is capable of repressing
IL-4 production in T-bet-deficient cells.
This suggests that T-bet-dependent re-
pression of Il4 may be through the ability
of T-bet to inhibit GATA3, and to induce
Runx3 expression, and not due to directeffects of T-bet on the Il4 locus. In support
of this, supplemental data of ChIP-seq
analysis indicates that CBF-b but not
T-bet bound to the Il4 HSIV element.
The characterization of Runx3 as a
GATA3-interacting protein adds further
complexity to our understanding of how
GATA3 interferes with Th1 cell-inducing
signaling pathways. Previous work has
demonstrated that GATA3 interferes with
the expression of IL-12Rb2 and IL-18Ra,
as well as STAT4, which is thought to be
a critical factor in maintaining the ability
of cells to acquire IFN-g-secreting poten-
tial (Usui et al., 2003; Yu et al., 2008)
(Figure 1). It is still not clear if GATA3
regulates Eomes directly, though the
increased expression of Eomes in Th cells
that lack STAT6 or GATA3 (Yang et al.,
2008; Yagi et al., 2010) supports the ability
of the IL-4 signaling pathway to potently
decrease Eomes expression. The direct
interaction of Runx3 with GATA3 facili-
tates another sensitive molecular switch
in developing Th cells. GATA3 not only
prevents Runx3 from activating IFN-g
and potentially other Th1 genes but also
inhibits it from repressing Il4. Thus, the
balance in the development of Th1 and
Th2 cells is controlled by the direct inter-
actions of these two transcription factors.ImmunityOne important caveat in interpreting
these experiments is realizing that Th2
cells transduced with Runx3 or Eomes
do not become Th1 cells, despite the
induction of IFN-g. The authors show
that Eomes is less efficient than T-bet in
the induction of Ifng and Il12rb2, although
they had similar abilities to induce
Cxcr3. This distinction is also seen when
comparing the intracellular staining for
IFN-g in Th1 cells and transcription
factor-transduced Th2 cells, or Gata3/
Th2 cells, considering both the percent-
age of positive cells and the fluorescence
intensity of the cells that are positive. The
ability of any one factor to promote only
a partial phenotype in the absence of
other factors again highlights the require-
ments for a network of transcription
factors in establishing a complete Th cell
phenotype. This network, summarized in
Figure 1 to indicate the multiple factors
that promote Ifng expression, as well as
those that are targets of GATA3-mediated
repression, provides a developing frame-
work for understanding how these and
other transcription factors cooperate in
programming gene expression and cell-
fate determination.
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